OTCPK:HDVY

Stock Analysis Report

Executive Summary

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Health Discovery's last earnings update was 1033 days ago.
  • Health Discovery is not covered by any analysts.

Share Price & News

How has Health Discovery's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-4.3%

HDVY

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

467.8%

HDVY

-9.0%

US Healthcare

1.1%

US Market

HDVY outperformed the Healthcare industry which returned -9.4% over the past year.

HDVY outperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

HDVYIndustryMarket
7 Day-4.3%0.008%-0.2%
30 Day0%-0.8%2.5%
90 Day3.1%-1.5%1.6%
1 Year467.8%467.8%-7.6%-9.0%3.4%1.1%
3 Year148.1%148.1%29.6%24.4%45.2%35.8%
5 Year235.0%235.0%66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Health Discovery's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Health Discovery undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Health Discovery is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Health Discovery has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Health Discovery's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Health Discovery regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Health Discovery expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health Discovery has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Health Discovery performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Insufficient past earnings data to establish if Health Discovery's year on year earnings growth rate was positive over the past 5 years.

Unable to compare Health Discovery's 1-year growth to the 5-year average as past earnings data has not been reported.

Unable to compare Health Discovery's 1-year growth to the US Healthcare industry average as past earnings data has not been reported.


Return on Equity

Unable to establish if Health Discovery has efficiently used shareholders’ funds last year as no Return on Equity data is available.


Return on Assets

Unable to establish if Health Discovery has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as past financial data has not been reported.


Return on Capital Employed

Unable to establish if Health Discovery improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.


Next Steps

Financial Health

How is Health Discovery's financial position?


In this section we usually analyse Health Discovery's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Health Discovery has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of HDVY’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Health Discovery's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Health Discovery's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Health Discovery's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Health Discovery's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Health Discovery has not reported any payouts.

Unable to verify if Health Discovery's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Health Discovery has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Health Discovery's salary, the management and board of directors tenure and is there insider trading?

4.4yrs

Average board tenure


CEO

George McGovern 0

2.6yrs

Tenure

0

Mr. George H. McGovern, III, has been the Chairman and Chief Executive Officer of Health Discovery Corporation since February 24, 2017. Mr. McGovern is a Co-Founder, Chairman and Chief Executive Officer at ...


Board Age and Tenure

4.4yrs

Average Tenure

63yo

Average Age

The tenure for the Health Discovery board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Richard Caruso (76yo)

    Founder and Senior Advisor

    • Tenure: 0yrs
    • Compensation: US$31.98k
  • George McGovern

    Chairman & CEO

    • Tenure: 2.6yrs
  • Hong Zhang (55yo)

    Senior Vice President of Computational Medicine

    • Tenure: 15.7yrs
    • Compensation: US$58.58k
  • Mark Moore (74yo)

    Vice President of Product Development

    • Tenure: 0yrs
    • Compensation: US$8.77k

Board Members

  • George McGovern

    Chairman & CEO

    • Tenure: 2.6yrs
  • James Murphy (63yo)

    Director

    • Tenure: 2.4yrs
  • Bernhard Schölkopf

    Member of the Scientific Advisory Board

    • Tenure: 15.8yrs
  • Kary Mullis

    Member of the Scientific Advisory Board

    • Tenure: 0yrs
  • Ramananda Madyastha (82yo)

    Member of Scientific Advisory Board

    • Tenure: 0yrs
    • Compensation: US$120.00k
  • Vladimir Vapnik

    Member of the Scientific Advisory Board

    • Tenure: 15.2yrs
  • Thomas Stamey

    Member of Scientific Advisory Board

    • Tenure: 15.2yrs
  • Rick Winger (77yo)

    Director

    • Tenure: 6.2yrs
    • Compensation: US$10.02k
  • Marty Delmonte (51yo)

    Director

    • Tenure: 2.5yrs
  • Edward Morrison (46yo)

    Director

    • Tenure: 2.4yrs

Company Information

Health Discovery Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Health Discovery Corporation
  • Ticker: HDVY
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$18.071m
  • Shares outstanding: 269.72m
  • Website: https://www.healthdiscoverycorp.com

Number of Employees


Location

  • Health Discovery Corporation
  • 4243 Dunwoody Club Drive
  • Suite 202
  • Atlanta
  • Georgia
  • 30350
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HDVYOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 2001

Biography

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United St ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 00:30
End of Day Share Price2019/09/19 00:00
Earnings2016/09/30
Annual Earnings2015/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.